Abbott (NYSE:ABT) and Edwards Lifesciences (NYSE:EW) said that they have agreed to settle all outstanding patent disputes related to transcatheter mitral and tricuspid repair products, and Edwards
Edwards Lifesciences has secured an important victory before the Unified Patent Court in its long-running heart valve dispute. The Nordic-Baltic division confirmed the patent in amended form and
total 1 pages, 2 items